Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 11, 2016 3:16 PM ET

Capital Markets

Company Overview of Capital International, Inc.

Company Overview

Capital International, Inc. is a privately owned investment manager. The firm primarily provides its services to individuals, corporate and public pension plans and profit sharing plans, pooled investment vehicles, foreign governmental entities, investment companies, corporations, state or municipal government entities, and institutions in Asia, Australia, and New Zealand. It manages client specific portfolios and investment funds for its clients. The firm invests in the public equity, fixed income, and private equity markets across the globe. Its equity investments includes of growth stocks. The firm’s fixed income investments include investment grade securities of governmental, supranation...

11100 Santa Monica Boulevard

15th Floor

Los Angeles, CA 90025-3384

United States

Founded in 1987





Key Executives for Capital International, Inc.

President, Portfolio Manager, and Director
Age: 57
Senior Vice President
Co-Founder, Senior Vice President, Research Director for Private Equity, Private Equity Senior Managing Partner, Director, and Vice Chairman of the Investment Committee
Managing Partner and Member of Investment Committee
Age: 52
Compensation as of Fiscal Year 2015.

Capital International, Inc. Key Developments

Two Funds Are Reportedly In Talks To Buy Mankind Stake

ChrysCapital may sell its eight-year-old investment in Mankind Pharma Limited at a price that is nearly 10 times the value of its original investment. Capital International, Inc. (Capital International Private Equity Funds) and Warburg Pincus LLC are in the final stages of negotiation with ChrysCapital to buy its 11% stake in Mankind Pharma, according to two people familiar with the development. The deal size is estimated at around $225 million-$250 million, they said. “ChrysCapital has received serious pre-emptive offers from a couple of global PE funds that have been forwarded to the Juneja family, promoters of Mankind Pharma. As Fund-IV comes to an end, it is true that ChrysCapital is in talks with the Junejas to provide an exit for their investment in Mankind latest by the end of calendar year 2015,” said Sanjiv Kaul, managing director, ChrysCapital. ChrysCapital has appointed Ernst & Young (EY) and Avendus Capital Private Limited as bankers for the transaction, according to the first person cited above. The process will be completed by August 2015-September 2015, he said. Spokespeople for Warburg Pincus and Capital International declined to comment citing company policy, reported Mint, and Mankind declined to comment on the stake sale in an email, saying the company’s “spokesperson is travelling”.

Capital International Reportedly Eyeing Mankind Pharma

Capital International, Inc. may be interested in acquiring Mankind Pharma Limited. According to the news report, Capital International is said to be in talks to acquire 11% cent stake in Mankind Pharma for INR 13 billion to INR 15 billion. A possible deal could lead to ChrysCapital exiting its. According to people close to the matter, besides Capital International, at least two other leading PE investors are said to be interested in buying the stake in Mankind Pharma. The promoters are said to have no plans to sell more stake to the new PE investor. The news report mentioned that ChrysCapital Managing Director Sanjiv Kaul said, “The unsolicited and pre-emptive offers that were received by ChrysCapital have been forwarded to the promoters of Mankind.” It further added that Chuck Freadhoff, a spokesperson for the Capital Group said, “We cannot comment on any business discussions Capital International PE might or might not be having with any firm.”

Temasek, Capital International Eye Avantha's Consumer Buz Stake

Capital International Inc., Temasek Holdings (Private) Limited and Bain Capital, LLC are keen to acquire a minority stake in Crompton Greaves Consumer Products of Avantha Holdings Limited. Avantha Holdings would sell a part of its 42.7 per cent stake in Crompton Greaves Consumer Products. Avantha Holdings directly owns 40.84% stake with the rest held by other investment entities. Gautam Thapar of Avantha announced that it is planning to sell around 7% stake in Crompton Greaves. As the news came out Crompton Greaves fell as much as 5.5% on November 27, 2014.

Similar Private Companies By Industry

Company Name Region
Samdrew IX Inc. United States
Associated European Capital LLC United States
Donaldson & Diwik, Inc. United States
South Dakota Trust Company, L.L.C. United States
MKM Partners LLC, Research Division United States

Recent Private Companies Transactions

September 2, 2015
British American Tobacco p.l.c.
July 17, 2015
Amoun Pharmaceutical Company S.A.E.
July 10, 2015
Closed Joint Stock Company Europlan

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Capital International, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at